Ryvu Therapeutics SA's total assets for Q4 2025 were zł224.44M, a decrease of -12.10% from the previous quarter. PL:RVU total liabilities were zł153.69M for the fiscal quarter, a -16.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.